Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans
- PMID: 2390929
- DOI: 10.1007/BF01537587
Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans
Abstract
Plaunotol, an acrylic diterpene alcohol, is a new antiulcer agent derived from the "plau-noi" plant and has been reported to stimulate the release of endogenous secretin in humans. We investigated the effect of plaunotol on postprandial gastrin release, comparing it to the effect of exogenous secretin in a physiological dose in eight healthy volunteers. Four sets of experiments were performed in each volunteer: (1) meal alone, (2) meal after intravenous ranitidine (50 mg), (3) meal after oral administration of plaunotol (320 mg) in addition to ranitidine, and (4) meal after ranitidine with simultaneous intravenous infusion of secretin (0.03 CU/kg/hr). The postprandial increase in plasma secretin concentration was significantly reduced by ranitidine, while postprandial gastrin release was markedly exaggerated. Plaunotol in combination with ranitidine significantly increased secretin release and inhibited gastrin release after a meal. Intravenous infusion of secretin resulted in significant suppression of postprandial gastrin release exaggerated by ranitidine. The present study indicates that plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action.
Similar articles
-
Effect of plaunotol on hypergastrinemia induced by long-term omeprazole administration in humans.Dig Dis Sci. 1995 Jan;40(1):160-5. doi: 10.1007/BF02063960. Dig Dis Sci. 1995. PMID: 7821104 Clinical Trial.
-
Secretin as a potential mediator of antiulcer actions of mucosal protective agents.J Clin Gastroenterol. 1991;13 Suppl 1:S83-7. doi: 10.1097/00004836-199112001-00014. J Clin Gastroenterol. 1991. PMID: 1940202 Review.
-
Effect of plaunotol on release of plasma secretin and pancreatic exocrine secretion in humans.Pancreas. 1989;4(3):323-8. doi: 10.1097/00006676-198906000-00008. Pancreas. 1989. PMID: 2471968
-
Role of endogenous prostaglandins in secretin- and plaunotol-induced inhibition of gastric acid secretion in the rat.Am J Gastroenterol. 1993 Jan;88(1):84-9. Am J Gastroenterol. 1993. PMID: 8420279
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
Cited by
-
Effect of plaunotol on hypergastrinemia induced by long-term omeprazole administration in humans.Dig Dis Sci. 1995 Jan;40(1):160-5. doi: 10.1007/BF02063960. Dig Dis Sci. 1995. PMID: 7821104 Clinical Trial.
-
Acute and chronic oral toxicity of a partially purified plaunotol extract from Croton stellatopilosus Ohba.Biomed Res Int. 2013;2013:303162. doi: 10.1155/2013/303162. Epub 2013 Sep 30. Biomed Res Int. 2013. PMID: 24286075 Free PMC article.
-
Role of endogenous secretin and cholecystokinin in intraduodenal oleic acid-induced inhibition of gastric acid secretion in rats.Dig Dis Sci. 1992 Mar;37(3):397-402. doi: 10.1007/BF01307734. Dig Dis Sci. 1992. PMID: 1735364
-
Effect of intraduodenal infusion of tocamphyl on pancreatic exocrine secretion and gastrointestinal hormone release in rats.Int J Pancreatol. 1994 Jun;15(3):187-93. doi: 10.1007/BF02924193. Int J Pancreatol. 1994. PMID: 7930779
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources